T Schneider
National Institute of Oncology(HU)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Thyroid Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Chronic Lymphocytic Leukemia Research, Cutaneous lymphoproliferative disorders research
Most-Cited Works
- → Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial(2012)128 cited
- → New treatment modalities in advanced thyroid cancer(2011)90 cited
- → Everolimus in patients with advanced follicular-derived thyroid cancer; results of a phase II clinical trial.(2016)90 cited
- → Everolimus pharmacokinetics and its exposure–toxicity relationship in patients with thyroid cancer(2016)52 cited
- → Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial(2015)48 cited
- → Sequential Study of Luteinizing Hormone (LH) and “Progestin” Secretion on the Afternoon of Proestrus in the Rat(1971)43 cited
- → Spermiogenesis and spermatozoa ultrastructure in five species of the Curimatidae with some considerations on spermatozoal ultrastructure in the Characiformes(2003)30 cited
- → Protective efficacy of different strategies employingMycobacterium lepraeheat-shock protein 65 against tuberculosis(2008)23 cited
- → (Secondary) solid tumors in thyroid cancer patients treated with the multi-kinase inhibitor sorafenib may present diagnostic challenges(2016)6 cited
- → Tyrosine kinase inhibitors in differentiated thyroid carcinoma: a review of the clinical evidence(2011)4 cited